ClinConnect ClinConnect Logo
Search / Trial NCT06770738

Correlation of the EUROSCORE-II With POSPOM in Cardiac Surgery: A Single Center, Retrospective, Cross- Sectional Study

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Jan 8, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying two scoring systems, EUROSCORE-II and POSPOM, to see how well they can predict the risk of death and complications after cardiac surgery. Cardiac surgery can be complex, especially for patients who may already have other health issues, so understanding a patient's condition before surgery is very important. The research is being conducted at Istanbul University-Cerrahpasa, Institute of Cardiology, and will involve patients who are 18 years or older and are undergoing specific types of heart surgeries, like coronary artery bypass grafting (CABG) or valve surgery.

If you or a family member are considering participating, you should know that the study is currently recruiting participants. Those involved will be monitored for any complications that might arise after surgery, such as bleeding, infections, or other serious issues. This trial aims to provide valuable information on how well these scoring systems work in predicting outcomes, which can help improve care for future cardiac surgery patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 and over, patients who have CABG surgery, valve surgery or both, and patients with on-pump surgery will be included in the study.
  • Exclusion Criteria:
  • . Patients under the age of 18, patients with off-pump surgery, and patients with non-cardiac vascular surgery will be excluded from the study.

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Kerem Erkalp, Dr

Principal Investigator

Professor

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported